Evommune raises $115M for I&I pipeline and prepares for Phase 2 results

Another inflammation and immunology startup has attracted big bucks.

On Thursday, Evommune announced a $115 million raise to back a pipeline anticipated to have multiple …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Which drugs are most likely to be approved in Somatic Pain?

Somatic Pain disease is an indication for drug development with over 150 pipeline drugs currently active according to GlobalData.

March 28, 2024

Salesforce Launches AI-Powered Life Sciences Cloud for Pharma and MedTech

What You Should Know: – Salesforce announced the general availability of Life Sciences Cloud, a platform for pharmaceutical (pharma) and medical technology (medtech) organizations to

June 19, 2024

For-profit hospitals are getting a boost from a flood of patients

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox every Monday.

July 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.